News & Updates
Filter by Specialty:

Real-world data support tirzepatide + hormone therapy for weight loss in postmenopausal women
In postmenopausal women with overweight or obesity, the use of tirzepatide alongside menopause hormone therapy appears to yield better weight loss outcomes than treating with tirzepatide alone, findings from a real-world analysis have shown.
Real-world data support tirzepatide + hormone therapy for weight loss in postmenopausal women
17 hours ago
Setmelanotide lowers BMI in patients with hypothalamic obesity
Treatment with setmelanotide results in significant BMI reductions in individuals with acquired hypothalamic obesity compared with placebo, with an acceptable safety profile, as shown by the results of a phase III study presented at ENDO 2025.
Setmelanotide lowers BMI in patients with hypothalamic obesity
a day ago
CSP vs BVP: Which one is better for HFrEF with non-LBBB?
In a meta-analysis comparing procedural and clinical outcomes between conduction system pacing (CSP) and biventricular cardiac resynchronization pacing (BVP), the former appears to outdo the latter for managing individuals with heart failure with reduced ejection fraction (HFrEF) without left bundle branch block (LBBB).